COMSTOCK HOLDING COMPANIES (CHCI)

US2056842022 - Common Stock

7.13  +0.72 (+11.23%)

Fundamental Rating

6

Overall CHCI gets a fundamental rating of 6 out of 10. We evaluated CHCI against 67 industry peers in the Real Estate Management & Development industry. CHCI scores excellent on profitability, but there are some minor concerns on its financial health. CHCI has a decent growth rate and is not valued too expensively.



9

1. Profitability

1.1 Basic Checks

CHCI had positive earnings in the past year.
In the past year CHCI had a positive cash flow from operations.
Each year in the past 5 years CHCI has been profitable.
CHCI had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

CHCI's Return On Assets of 15.76% is amongst the best of the industry. CHCI outperforms 100.00% of its industry peers.
The Return On Equity of CHCI (21.15%) is better than 96.97% of its industry peers.
CHCI's Return On Invested Capital of 19.37% is amongst the best of the industry. CHCI outperforms 98.48% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CHCI is significantly above the industry average of 5.49%.
The last Return On Invested Capital (19.37%) for CHCI is above the 3 year average (17.96%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 15.76%
ROE 21.15%
ROIC 19.37%
ROA(3y)22.97%
ROA(5y)16.15%
ROE(3y)35.73%
ROE(5y)27.33%
ROIC(3y)17.96%
ROIC(5y)15.67%

1.3 Margins

CHCI's Profit Margin of 17.56% is amongst the best of the industry. CHCI outperforms 92.42% of its industry peers.
CHCI's Profit Margin has improved in the last couple of years.
CHCI has a better Operating Margin (20.40%) than 89.39% of its industry peers.
In the last couple of years the Operating Margin of CHCI has grown nicely.
Looking at the Gross Margin, with a value of 26.19%, CHCI is in line with its industry, outperforming 57.58% of the companies in the same industry.
In the last couple of years the Gross Margin of CHCI has grown nicely.
Industry RankSector Rank
OM 20.4%
PM (TTM) 17.56%
GM 26.19%
OM growth 3Y19.53%
OM growth 5Y62.13%
PM growth 3Y23.09%
PM growth 5YN/A
GM growth 3Y13.68%
GM growth 5Y31.25%

5

2. Health

2.1 Basic Checks

CHCI has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
CHCI has more shares outstanding than it did 1 year ago.
CHCI has more shares outstanding than it did 5 years ago.
CHCI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

CHCI has an Altman-Z score of 0.07. This is a bad value and indicates that CHCI is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.07, CHCI is doing worse than 68.18% of the companies in the same industry.
CHCI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 0.07
ROIC/WACC2.07
WACC9.34%

2.3 Liquidity

A Current Ratio of 1.51 indicates that CHCI should not have too much problems paying its short term obligations.
With a Current ratio value of 1.51, CHCI perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
CHCI has a Quick Ratio of 1.51. This is a normal value and indicates that CHCI is financially healthy and should not expect problems in meeting its short term obligations.
CHCI has a Quick ratio (1.51) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.51
Quick Ratio 1.51

4

3. Growth

3.1 Past

CHCI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -23.64%.
The Earnings Per Share has been growing by 45.50% on average over the past years. This is a very strong growth
The Revenue has grown by 14.04% in the past year. This is quite good.
The Revenue has been growing by 22.22% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-23.64%
EPS 3Y45.5%
EPS 5YN/A
EPS growth Q2Q41.22%
Revenue 1Y (TTM)14.04%
Revenue growth 3Y25.73%
Revenue growth 5Y22.22%
Revenue growth Q2Q18.45%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 9.38 indicates a reasonable valuation of CHCI.
95.45% of the companies in the same industry are more expensive than CHCI, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of CHCI to the average of the S&P500 Index (24.92), we can say CHCI is valued rather cheaply.
Industry RankSector Rank
PE 9.38
Fwd PE N/A

4.2 Price Multiples

96.97% of the companies in the same industry are more expensive than CHCI, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CHCI indicates a rather cheap valuation: CHCI is cheaper than 87.88% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 7.99
EV/EBITDA 4.71

4.3 Compensation for Growth

The excellent profitability rating of CHCI may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CHCI!.
Industry RankSector Rank
Dividend Yield N/A

COMSTOCK HOLDING COMPANIES

NASDAQ:CHCI (4/26/2024, 7:00:00 PM)

7.13

+0.72 (+11.23%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap69.95M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 9.38
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 15.76%
ROE 21.15%
ROCE
ROIC
ROICexc
ROICexgc
OM 20.4%
PM (TTM) 17.56%
GM 26.19%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.51
Quick Ratio 1.51
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-23.64%
EPS 3Y45.5%
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)14.04%
Revenue growth 3Y25.73%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y